This is a lecture by Dr. Jim Holliman from the Ghana Emergency Medicine Collaborative. To download the editable version (in PPT), to access additional learning modules, or to learn more about the project, see http://openmi.ch/em-gemc. Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/.
snake poisoning with variety of snakes and identification features, conservative treatment.Antitoxin treatment with a note on the drugs used to treat antitoxin reactions, Venom composition and venom classification, types of snakes and features. snake bite treatment at different levels of healthcare systems in India.
This is a lecture by Dr. Jim Holliman from the Ghana Emergency Medicine Collaborative. To download the editable version (in PPT), to access additional learning modules, or to learn more about the project, see http://openmi.ch/em-gemc. Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/.
snake poisoning with variety of snakes and identification features, conservative treatment.Antitoxin treatment with a note on the drugs used to treat antitoxin reactions, Venom composition and venom classification, types of snakes and features. snake bite treatment at different levels of healthcare systems in India.
Snakebite in Zimbabwe: Venomous Snakes and ManagementDexter Tagwireyi
This slide describes snakebite in Zimbabwe with an emphasis on the important venomous snake families, and the clinical presentation of patients bitten by ZImbabwean venomous snakes.
Blue tongue is a non-contagious, infectious, arthropod-borne viral disease of sheep, goat, cattle and deer, with a worldwide distribution. Initially, the disease was reported in sheep in South Africa in 1881 and it was ascribed as “epizootic catarrh”. In 1905, the disease was renamed as “blue tongue”. In India, the first outbreak of blue tongue disease in sheep and goat was reported by Sapre (1964) from Maharashtra. It is listed under category ‘A’ of disease by OIE. The presence of this disease disrupts international commerce by putting a trade barrier on the movement of animals, their germplasm as well as animal products (OIE Bulletin, 1998).
Snake bite poisoning and its treatment by RxVichuZ!RxVichuZ
My 106th powerpoint...that deals with snake bite poisoning.
Different types of venomous snakes, their characteristics, envenomation features and treatment strategies have been explained in a summary.
Hope it is effective for the readers involved.
Snakebite Prevention and Control - Indian Scenario Dr Purabi.pptxDr Purabi Phukan
An overview Snake Bite Envenomation a neglected tropical Disease. The PPt highlights the snakebie buren in India and the current challenges its in prevention and control and way forward to plan a comprehensive program for this prevention and control.
Snakebite in Zimbabwe: Venomous Snakes and ManagementDexter Tagwireyi
This slide describes snakebite in Zimbabwe with an emphasis on the important venomous snake families, and the clinical presentation of patients bitten by ZImbabwean venomous snakes.
Blue tongue is a non-contagious, infectious, arthropod-borne viral disease of sheep, goat, cattle and deer, with a worldwide distribution. Initially, the disease was reported in sheep in South Africa in 1881 and it was ascribed as “epizootic catarrh”. In 1905, the disease was renamed as “blue tongue”. In India, the first outbreak of blue tongue disease in sheep and goat was reported by Sapre (1964) from Maharashtra. It is listed under category ‘A’ of disease by OIE. The presence of this disease disrupts international commerce by putting a trade barrier on the movement of animals, their germplasm as well as animal products (OIE Bulletin, 1998).
Snake bite poisoning and its treatment by RxVichuZ!RxVichuZ
My 106th powerpoint...that deals with snake bite poisoning.
Different types of venomous snakes, their characteristics, envenomation features and treatment strategies have been explained in a summary.
Hope it is effective for the readers involved.
Snakebite Prevention and Control - Indian Scenario Dr Purabi.pptxDr Purabi Phukan
An overview Snake Bite Envenomation a neglected tropical Disease. The PPt highlights the snakebie buren in India and the current challenges its in prevention and control and way forward to plan a comprehensive program for this prevention and control.
Rabies is entirely preventable, and vaccines,
medicines, tools, and technologies have long
been available to prevent people from dying of
dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over
40% are children under 15, mainly in rural areas
of economically disadvantaged countries in Africa
and Asia. Of all human cases, up to 99% are
acquired from the bite of an infected dog.
Estimation of Phytochemical Components from Cassia Tora and To Study Its Larv...inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Kumar m, tiwari l. snake bite a review jpcc 2018Lokesh Tiwari
Snake bite is a common but under-reported medical emergency accounting for 0.5% of all deaths with greater risk of fatal envenomation in children. In India, four species of venomous snake are most common but better classification of medically significant species is warranted. Snake venom is a mixture of peptides with enzymatic & toxic properties which mediate activation of cytokine cascades along with organ specific toxicities, manifesting into local and systemic symptoms. The syndromic approach of attributing a constellation of signs & symptoms to a particular family of venomous snake has clinical acceptance but overlaps exist. Management of snake bite victim starts with a first aid measures of reassurance, immobilization and quick transfer to hospital. Measures such as application of tourniquet, incision and suction are harmful & should not be done. On arrival at hospital, triage and stabilization of Airway, Breathing & Circulation (ABC) is done followed by a focused assessment to ascertain the severity of envenomation. Antivenom treatment is the mainstay of snake bite management. ASV should be started only when specific indications such as signs of neurotoxicity, coagulopathy, hypotension, hematuria are present. Indiscriminate use of ASV is strongly condemned.Currently 8-10 vials of ASV as initial dose with a maximum of 25 vials is recommended. There is no role of test dose of ASV. Measures to treat any ASV induced anaphylaxis should be ready prior to start of ASV treatment. Supportive treatment is as important in determining the final outcome of envenomation as ASV
The Assessment of Human-Snake Interaction and its Outcome in the City of KumbaAI Publications
Throughout history humans have had an uneasy relationship with serpents. Snakes are animals that fascinate many people while frightening others, good or bad, most people have strong feelings about snakes, but few people remain neutral. Most human-snake interactions had lead to the destruction of snakes due to human inability to control fear and panic. The indiscriminate killing of snakes for presumed human safety has drastically reduced the population of many snake species to the level of extirpation. The objective of this, however, is to examine the human interaction with snakes in city of Kumba. To get this survey done, a total number of two hundred and fifty questionnaires were administered to a randomly selected population sample in the study area. The results of the survey revealed that the prevention of snake attacks and the opinion of people on snake population management is significantly related (X2 = 11.069 df=4, P<0.05).The importance of snakes and their medical need for snake venom has showed a significant agreement (X2 = 12.045 df=2, P<0.05). Also, the prevention of snake attacks and the area snakes are easily sighted showed a significant association (X2 = 29.205 df=4, P<0.05). In addition, there is a significant link between the snake-bite treatment and its prevention (R2 = 0.312, P<0.05). Moreso, a respondent score of 39.30% is recorded upon the knowledge of venomous snakes. Furthermore, the study recorded a respondent score of 39.30% on the preferable use of traditional treatment on snake-bite victim than the expected medical treatment (31.84%), creating an understanding that the people of Kumba are still very much dependent on the ancient methods of treating snake-bite victims. The Kumba city dwellers need education on the snake behaviour, venomous and non venomous species around their area and the ecological and medical importance of snakes.
Tick-borne parasitic infections are serious problem in the world as the population of ticks is increasing with people building homes in areas where ticks and their host live. Ticks are second to mosquitoes as an excellent vector for vector-borne diseases. There are only two known tick-borne parasitic infections: Babesiosis and Theileriosis. Babesiosis is due to the tick-borne parasites of the Babesia protozoa genus while Theileriosis is caused by Theilerias species which are obligate protozoan parasites. They are both transmitted by the Ixodid ticks. The symptoms of the infection includes lacrimation, nasal discharge, muscle pains etc. Tick-borne parasitic diseases can be prevented by avoiding places where ticks often live and also by using insect repellents.
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONAmeena Kadar
Different types of reviews of literature and it's sources are included in this PowerPoint. A review of the literature is an inevitable part of the research process.
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxAmeena Kadar
Genetic Polymorphism is one of the factors that affects the Drug metabolism. Cytochrome P - 450, one of the prominent group of metabolizing enzymes. In this ppt, genetic polymorphism of cytochrome p 450 is discussed.
Anemia is one of the most commonly seen condition predominantly in women due to various causes such as some chronic infection conditions and all. There are different types of anemias are there here we discuss mainly about Iron deficiency and sickle cell anemia.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
1. SNAKEBITE ENVENOMATION: PATHOPHYSIOLOGY
MANAGEMENT & TREATMENT
*Ameena kadar K.A, Aneeza V.A , Divya V, Baskar L
GRACE COLLEGE OF PHARMACY, PALAKKAD, 678004.
INTRODUCTION DISEASE WORSEN
PATHOPHYSIOLOGY
.
ABSTRACT
Medical
The purpose of this review is to
address some of the information
about pathophysiology, treatment
and management of snakebite
envenomation. Envenomation after
snakebite is an underestimated and
neglected public health issue
responsible for substantial illness
and death as well as socioeconomic
hardship to impoverished
populations living in rural and
tropical Africa, Asia, Oceania, and
Latin America. In developed
nations, snake bite typically occurs
during recreational activities,
whereas in developing countries it
is an occupational disease more
likely to affect young agricultural
workers, predominantly men.
Scarcity and delay of administration
of antivenom, poor health services,
and difficulties with transportation
from rural areas to health centers
are major factors that contribute to
the high case-fatality ratio of
snakebite envenomation. There are
around 3500 snakes species in the world
and out of which 600 venomous. There are
270 plus species of snakes in India, in that
60 are highly venomous.
Teach communities to prevent snakebites
and to make right treatment choices,
make antivenoms
safe, effective, affordably accessible to
all , these are the solutions existing in
order to mould a healthy nation.
India is a country known to the
western population as a country of
snake charmers and snake over
centuries. Despite generation after
generations some families in our
country who play with snakes (snake
charmers), we fail to protect the
community from snake bite which
requires at least education of the
common people, how to protect
themselves from snake bite as well as
what to do after the bite has occurred.
The estimated death in India is 50,000/
year, an underestimate because of lack
of proper registration of snakebite.
The real number of death in our
country probably much higher.
REFERENCES
1. Gudilines For the Clinical Management Of Snake Bites In South-
East Asia Region Written and edited by David A Warrell published
by WHO, 2005.
2. J Srimannaryan, TK Dutta, A Sahai, S Badrinath. Rational Use of
Anti-Snake Venom(ASV): Trial of Various Regimens in Hemotoxic
snake Envenomation, JAPI 2004; 52:788- 792.
Snake venom consists of toxic saliva secreted
by modified parotid salivary gland of venomous
snake. Venom appears as clear and amber
coloured.
ef
MECHANISM OF ACTION (SNAKE VENOM)
FIRST AID MEASURES
HOSPITAL MEASURES
Anti Snake Venom (ASV)
In India polyvalent ASV is only available, It is
effective against all the four common species;
Russells viper (Daboia russelii), Common Cobra
(raja naja), Common Krait (Bungarus caeruleus)
and Saw Scaled viper (Echis carinatus).
TREATMENT
CONCLUSION
Snakes do not generally attack human unless provoked. However,
once bitten, a wide spectrum of clinical manifestations may result.
Delayed medical management & lack of public awareness results in
prolonged hospital and ICU stay of the patients.
This can be decreased if regular public programmes regarding
prevention, prehospital management(First aid), and the importance of
early transfer to hospital are conducted.
Identification of the species of snake responsible for the bite is
important for optimal clinical management.
Antivenom is the only effective antidote for snake venom. Aware
about the appropriate first aid for snakebite.
Conserve the endangered species of snakes, they also has the right
to live.
NEED NOT KILL, BE AWARE, BE SAFE.
SNAKES
Also known as “Serpents”, limbless
creatures with elongated bodies, covered
with scales.
Of more than 3000 known species of snakes,
only about 300 are venomous and in India
there are about 216 identifiable species of
snakes, of which 52 are known to be
poisonous.
The major families of poisonous snakes in
India are Elapid which includes common
cobra (Naja naja), king cobra and common
krait (Bungarus caerulus, Banded krait, Sind
krait), viperidae (Russell’s viper), Echis
carinatus (sawscaled or carpet viper), and pit
viper and hydrophiidae (sea snakes).
Recently, venomous viper called hope nosed
viper is reported from Cochin region.
SNAKEBITE MANAGEMENT